Prepare for your visit
Kavitha Velicheti
Pediatrics · Edison, NJ · NPI 1033310404
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$2,251.75
in general payments reported to CMS, 2019-2025 · $887 in 2025
The $887 reported for 2025 was more than what 97% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Who reported paying
General payments only, top 6 by amount.
- Ucb, INC. $545.03
- Sk Life Science, INC. $415.91
- Argenx US, INC. $112.57
- Medtronic USA, INC. $92.02
- Averitas Pharma INC. $91.00
- Livanova USA, INC. $82.64
Drugs and devices associated with these payments
Fintepla Briviact Qutenza Vns Therapy Sentiva Model 1000 Generator Vyvgart Hytrulo Valtoco Qelbree Sympazan Gamunex-C Ultomiris Botox Synchromedii
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Kavitha Velicheti listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/228511/kavitha-velicheti